E-LIB Suche - Ergebnisse für: Shirai, Fumiyuki

1

The development of a custom RNA-sequencing panel for the id..:

Shirai, Yukina ; Ueno, Toshihide ; Kojima, Shinya...
Journal of Neuro-Oncology. 167 (2024) 1 - p. 75-88 , 2024

Link: https://doi.org/10.1007/..

2

Lymphangioleiomyomatosis as a potent lung cancer risk facto..:

Torasawa, Masahiro ; Shukuya, Takehito ; Uemura, Kohei...
Respirology. , 2024

Link: https://doi.org/10.1111/..

3

An ex vivo screening using mouse brain mitochondria identif..:

Kubota-Sakashita, Mie ; Kawakami, Hirochika ; Kikuzato, Ko...
Biochemical and Biophysical Research Communications. 691 (2024) - p. 149253 , 2024

Link: https://doi.org/10.1016/..

4

Reduction of H3K9 methylation by G9a inhibitors improves th..:

Matoba, Shogo ; Shikata, Daiki ; Shirai, Fumiyuki...
Stem Cell Reports. 19 (2024) 6 - p. 906-921 , 2024

Link: https://doi.org/10.1016/..

5

BET protein–dependent E2F pathway activity confers bell-sha..:

Morino, Shun ; Mashima, Tetsuo ; Shirai, Fumiyuki...
Cancer Letters. 584 (2024) - p. 216632 , 2024

Link: https://doi.org/10.1016/..

6

Structure-based development of novel substrate-type G9a inh..:

Nishigaya, Yosuke ; Takase, Shohei ; Sumiya, Tatsunobu...
Bioorganic & Medicinal Chemistry Letters. 110 (2024) - p. 129856 , 2024

Link: https://doi.org/10.1016/..

7

APC/PIK3CA mutations and β-catenin status predict tankyrase..:

Chen, Mingjue ; Mashima, Tetsuo ; Oishi, Taichi...
British Journal of Cancer. 130 (2023) 1 - p. 151-162 , 2023

Link: https://doi.org/10.1038/..

8

Discovery of Novel Substrate-Competitive Lysine Methyltrans..:

Nishigaya, Yosuke ; Takase, Shohei ; Sumiya, Tatsunobu...
Journal of Medicinal Chemistry. 66 (2023) 6 - p. 4059-4085 , 2023

Link: https://doi.org/10.1021/..

9

A specific G9a inhibitor unveils BGLT3 lncRNA as a universa..:

Takase, Shohei ; Hiroyama, Takashi ; Shirai, Fumiyuki...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

10

A specific G9a inhibitor unveils BGLT3 lncRNA as a universa..:

Shohei Takase ; Takashi Hiroyama ; Fumiyuki Shirai...
https://doi.org/10.1038/s41467-022-35404-0. , 2023

Link: https://doi.org/10.1038/..

11

Novel tankyrase inhibitors suppress TDP-43 aggregate format..:

Tanji, Kunikazu ; Mori, Fumiaki ; Shirai, Fumiyuki...
Biochemical and Biophysical Research Communications. 537 (2021) - p. 85-92 , 2021

Link: https://doi.org/10.1016/..

12

Design and Discovery of an Orally Efficacious Spiroindolino..:

Shirai, Fumiyuki ; Mizutani, Anna ; Yashiroda, Yoko...
Journal of Medicinal Chemistry. 63 (2020) 8 - p. 4183-4204 , 2020

Link: https://doi.org/10.1021/..

13

Discovery of Novel Spiroindoline Derivatives as Selective T..:

Shirai, Fumiyuki ; Tsumura, Takeshi ; Yashiroda, Yoko...
Journal of Medicinal Chemistry. 62 (2019) 7 - p. 3407-3427 , 2019

Link: https://doi.org/10.1021/..

14

DOCK1 inhibition suppresses cancer cell invasion and macrop..:

Tomino, Takahiro ; Tajiri, Hirotada ; Tatsuguchi, Takaaki...
Biochemical and Biophysical Research Communications. 497 (2018) 1 - p. 298-304 , 2018

Link: https://doi.org/10.1016/..

15

RK‐287107, a potent and specific tankyrase inhibitor, block..:

Mizutani, Anna ; Yashiroda, Yoko ; Muramatsu, Yukiko...
Cancer Science. 109 (2018) 12 - p. 4003-4014 , 2018

Link: https://doi.org/10.1111/..